Lonza confirms outlook as it expects more contracts in coming months - Reuters
#Lonza confirms#confirms outlook#coming months#Reuters Lonza#months Reuters
Life Science News
Latest updates from the biotech and pharma world
Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) - Technology Networks
#Technology Networks#Receives Swissmedic#Swissmedic Approval#Highly Potent#Potent Biologics
CPHI 2025: Lonza Capsugel spotlights delivery tech and sustainability in nutraceuticals - nutritioninsight.com
#Lonza Capsugel#Capsugel spotlights#spotlights delivery#delivery tech#nutritioninsight.com CPHI
GBCC and Lonza partner for apprenticeship program - NH Business Review
#Business Review#Lonza partner#Review GBCC#apprenticeship program#Lonza
Lonza expands its GMP solutions for cell and gene therapy - SelectScience
#GMP solutions#Lonza expands#gene therapy#GMP#SelectScience Lonza
Lonza Capsugel launches organic, vegan capsule line - SupplySide Supplement Journal
#Supplement Journal#Lonza Capsugel#Capsugel launches#launches organic#vegan capsule
Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) - the-scientist.com
#Lonza Receives#Receives Swissmedic#Swissmedic Approval#Highly Potent#Potent Biologics
Is Now An Opportune Moment To Examine Lonza Group AG (VTX:LONN)? - Yahoo Finance
#Opportune Moment#Examine Lonza#Lonza Group#VTX#LONN
Lonza Group: Growth, Signs Of Overvaluation, And A New Management Cause Uncertainty - Seeking Alpha
#Lonza Group#Seeking Alpha#Uncertainty Seeking#Growth#Alpha Lonza
Lonza Completes New Drug Product Filling Line in Stein, Switzerland - Contract Pharma
#Drug Product#Product Filling#Filling Line#Contract Pharma#Lonza Completes
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire
#Therapeutic Innovations#Forecast Report#Featuring Lonza#Novo Nordisk#Market Therapeutic
Lonza Expands TheraPEAK® Portfolio to Strengthen Support for Gene and Cell Therapy Development - Lab Manager
#Strengthen Support#Cell Therapy#Expands TheraPEAK#Therapy Development#Lab Manager
Lonza Expands Cell and Gene Therapy Portfolio - Contract Pharma
#Expands Cell#Gene Therapy#Therapy Portfolio#Contract Pharma#Lonza Expands
Lonza Announces Innovation Day at SupplySide Global - WholeFoods Magazine
#Announces Innovation#Innovation Day#Lonza Announces#SupplySide Global#WholeFoods Magazine
Lonza announces new board nominee - The Vacaville Reporter
#Vacaville Reporter#Lonza announces#Reporter Lonza#board nominee#Vacaville
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Synaffix Collaborates#Qurient Therapeutics#ADC Development#Dual-Payload ADC
Lonza’s Synaffix and Qurient team up on dual-payload ADC - The Pharma Letter
#Pharma Letter#Qurient team#dual-payload ADC#Letter Lonza#Synaffix
RION engages Lonza to scale manufacturing exosome based therapeutics - News-Medical
#engages Lonza#RION engages#scale manufacturing#manufacturing exosome#exosome based
Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC - Yahoo Finance
#Synaffix Collaborates#Qurient Therapeutics#Enable Development#Yahoo Finance#Lonza Synaffix
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics - Business Wire
#Engages Lonza#Scale Manufacturing#Manufacturing Exosome#Exosome Based#RION Engages